Phase 1 Study of Two Merozoite Surface Protein 1 (MSP1₄₂) Vaccines for Plasmodium falciparum Malaria

• Elissa Malkin,

  Affiliation Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America

  ⨯
• Carole A Long,

  Affiliation Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America

  ⨯
• Anthony W Stowers,

  Affiliation Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America

  ⨯
• Lanling Zou,

  Affiliation Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America

  ⨯
• Sanjay Singh,

  Affiliation Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America

  ⨯
• Nicholas J MacDonald,

  Affiliation Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America

  ⨯
• David L Narum,

  Affiliation Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America

  ⨯
• Aaron P Miles,

  Affiliation Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America

  ⨯
• Andrew C Orcutt,

  Affiliation Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America

  ⨯
• Olga Muratova,

  Affiliation Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America

  ⨯
• Samuel E Moretz,

  Affiliation Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America

  ⨯
• Hong Zhou,

  Affiliation Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America

  ⨯
• Ababacar Diouf,

  Affiliation Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America

  ⨯
• Michael Fay,

  Affiliation Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Eveline Tierney,

  Affiliation PATH Malaria Vaccine Initiative, Bethesda, Maryland, United States of America

  ⨯
• Philip Leese,

  Affiliation Quintiles Phase 1 Services, Lenexa, Kansas, United States of America

  ⨯
• Siddhartha Mahanty,

  Affiliation Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America

  ⨯
• Louis H Miller,

  Affiliation Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America

  ⨯
• Allan Saul,

  Affiliation Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America

  ⨯
•  [ ... ],
• Laura B Martin

  *To whom correspondence should be addressed. E-mail: LMartin@niaid.nih.gov

  Affiliation Malaria Vaccine Development Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America

  ⨯
• [ view all ]
• [ view less ]